TM6SF2 variant rs58542926 has also been associated with an increased risk of developing advanced hepatic fibrosis and cirrhosis in patients with non-alcoholic fatty liver disease (NAFLD) [13]. The gene discussed is TM6SF2; the disease is metabolic dysfunction-associated steatotic liver disease.